# ClinicalTrials.gov record NCT00532545

> PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00532545-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2007-09-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00532545-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00532545-teriparatide-v1.json
- Content SHA-256: `648d64ab09f782bd8f0be750db3fce1bf9a85ab2c49411ca91b73131dd856269`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00532545 ([`ctg-observation-nct00532545-2007-09-20-f7b445d078a2`](#source-ctg-observation-nct00532545-2007-09-20-f7b445d078a2))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00532545-2007-09-20-f7b445d078a2`](#source-ctg-observation-nct00532545-2007-09-20-f7b445d078a2))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00532545-2007-09-20-f7b445d078a2`](#source-ctg-observation-nct00532545-2007-09-20-f7b445d078a2))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00532545-2007-09-20-f7b445d078a2`](#source-ctg-observation-nct00532545-2007-09-20-f7b445d078a2))

## Sources

<a id="source-ctg-observation-nct00532545-2007-09-20-f7b445d078a2"></a>
- **ClinicalTrials.gov record NCT00532545 · retained source version 2007-09-20:f7b445d078a2ce2f7d9f6377d973f602df938966b060f1037c16cdf0fc1d2ed3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00532545) (`ctg-observation-nct00532545-2007-09-20-f7b445d078a2`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00532545." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00532545-teriparatide-v1.json SHA-256: 648d64ab09f782bd8f0be750db3fce1bf9a85ab2c49411ca91b73131dd856269.